| Quarterly Financials | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
Revenue  | 53 | 61 | 53 | 56 | 62 | 68 | 60 | 66 | 74 | 80 | 78 |
| Expenses | 37 | 39 | 37 | 37 | 40 | 44 | 41 | 46 | 49 | 55 | 55 |
| EBITDA | 16 | 21 | 16 | 20 | 22 | 25 | 19 | 20 | 25 | 25 | 24 |
| Operating Profit % | 28 % | 35 % | 30 % | 34 % | 34 % | 35 % | 31 % | 29 % | 33 % | 31 % | 30 % |
| Depreciation | 8 | 8 | 8 | 8 | 9 | 9 | 9 | 9 | 10 | 10 | 11 |
| Interest | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 |
| Profit Before Tax | 5 | 11 | 6 | 9 | 11 | 14 | 8 | 9 | 13 | 12 | 10 |
| Tax | 1 | 3 | 2 | 3 | 3 | 4 | 2 | 2 | 3 | 3 | 3 |
| Net Profit | 4 | 8 | 5 | 6 | 8 | 10 | 6 | 7 | 9 | 9 | 7 |
| EPS in ₹ | 1.17 | 2.44 | 0.87 | 1.22 | 1.49 | 1.94 | 1.18 | 1.42 | 1.80 | 1.73 | 1.44 |
Suraksha Diagnostic
Suraksha Diagnostic
305.05
+5.55
(1.85%)
Market Cap
1,588.72 Cr
PE Ratio
48.28
Volume
56,538.00
Day High - Low
308.40 - 296.40
52W High-Low
352.50 - 224.10
Key Fundamentals
Market Cap
1,588.72 Cr
EPS
5.97
PE Ratio
48.28
PB Ratio
6.79
Book Value
44.24
EBITDA
85.10
Dividend Yield
0.00 %
Industry
Healthcare Services Sector
Healthcare Service Provider Return on Equity
14.74
Debt to Equity
0.46
Analyst Rating and Forecast
- By Refinitiv from1 analysts
Actual
Company News
View All News
Suraksha Diagnostic Limited schedules a virtual earnings call on Friday, 22 May 2026 at 12:00 PM IST to discuss Q4 & FY 2025-26 audited financial results with analysts and investors.
Suraksha Diagnostic's board will meet on May 21, 2026, to consider audited financial results for Q4 and FY26, and to deliberate on dividend recommendation for FY26.
Suraksha Diagnostic promoters, led by Dr. Somnath Chatterjee, declare no encumbrance of shares for FY26 under SEBI Regulation 31(4), dated 03 April 2026.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,668.60 | #1 27,958.23 | 56.06 | #1 2,762.90 | 8.15 | #1 510 | -14.98 | 65.22 | |
1,271.70 | 13,085.38 | 77.35 | 814.20 | 16.36 | 182 | 37.25 | 64.74 | |
518.30 | 10,745.80 | 55.16 | 1,645.85 | 22.25 | 185 | 74.66 | 56.56 | |
475.25 | 7,564.33 | 46.03 | 829.04 | 18.06 | 156 | 125.46 | 66.47 | |
614.10 | 6,161.92 | 91.48 | 769.90 | 33.97 | 67 | 22.09 | 61.45 | |
562.80 | 1,825.65 | 22.83 | 742.70 | 16.70 | 78 | -21.13 | 37.57 | |
305.05 | #7 1,588.72 | #6 48.28 | #8 255.90 | #8 15.11 | #8 31 | #8 20.00 | 62.59 | |
1,263.00 | 1,083.99 | 18.65 | 111.60 | 28.72 | 48 | 65.93 | 46.42 | |
288.15 | 916.62 | 31.26 | 1,170.80 | -18.47 | -134 | 101.06 | 54.59 | |
459.75 | 898.50 | #1 13.74 | 147.80 | #1 134.60 | 19 | #1 520.00 | 44.23 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
15.11 %
Net Income Growth
34.20 %
Cash Flow Change
4.76 %
ROE
14.18 %
ROCE
10.95 %
EBITDA Margin (Avg.)
0.39 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 173 | 171 | 201 | 281 | 300 | 334 |
| Fixed Assets | 128 | 119 | 119 | 195 | 212 | 223 |
| Current Assets | 28 | 27 | 22 | 68 | 72 | 47 |
| Capital Work in Progress | 0 | 0 | 1 | 2 | 1 | 11 |
| Investments | 5 | 5 | 0 | 0 | 0 | 1 |
| Other Assets | 39 | 47 | 80 | 84 | 87 | 99 |
| Total Equity & Liabilities | 173 | 171 | 201 | 281 | 300 | 334 |
| Current Liabilities | 34 | 25 | 28 | 38 | 39 | 43 |
| Non Current Liabilities | 19 | 20 | 23 | 87 | 82 | 81 |
| Total Equity | 120 | 126 | 150 | 156 | 179 | 210 |
| Reserve & Surplus | 111 | 118 | 141 | 147 | 171 | 201 |
| Share Capital | 9 | 9 | 9 | 9 | 9 | 10 |
Cash Flow
| Cash Flow | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 1 | -1 | -0 | -1 | 0 | -0 |
| Investing Activities | -20 | -28 | -44 | -21 | -35 | -40 |
| Operating Activities | 31 | 24 | 42 | 44 | 61 | 63 |
| Financing Activities | -10 | 3 | 1 | -24 | -25 | -24 |
Share Holding
| % Holding | Jul 2024 | Nov 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
| Promoter | 72.41 % | 61.06 % | 48.78 % | 48.78 % | 48.88 % | 48.98 % | 49.00 % | 49.10 % |
| FIIs | 0.00 % | 0.00 % | 15.39 % | 14.46 % | 13.95 % | 13.72 % | 13.46 % | 13.46 % |
| DIIs | 0.00 % | 0.00 % | 20.44 % | 22.05 % | 22.37 % | 21.98 % | 22.57 % | 23.14 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 0.00 % | 14.08 % | 13.52 % | 13.08 % | 12.96 % | 12.60 % | 12.08 % |
| Others | 27.59 % | 38.94 % | 1.31 % | 1.19 % | 1.71 % | 2.36 % | 2.38 % | 2.23 % |
| No of Share Holders | 10 | 10 | 10 | 87,275 | 79,670 | 75,304 | 70,963 | 67,107 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 21 May 2026 |  Quarterly Result Announcement | NA | 21 May 2026 | 290.80 | 299.50 |
| 20 Dec 2024 | Quarterly Result Announcement | NA | 20 Dec 2024 | 411.35 | 408.00 |
| 08 Feb 2025 | Quarterly Result Announcement | NA | 08 Feb 2025 | 311.80 | 347.15 |
| 28 May 2025 | Quarterly Result Announcement | NA | 28 May 2025 | 314.65 | 326.95 |
| 08 Aug 2025 | Quarterly Result Announcement | NA | 08 Aug 2025 | 304.80 | 290.45 |
| 05 Sept 2025 |  Annual General Meeting | NA | 05 Sept 2025 | 326.95 | 302.70 |
| 10 Nov 2025 | Quarterly Result Announcement | NA | 10 Nov 2025 | 317.80 | 319.40 |
| 05 Feb 2026 | Quarterly Result Announcement | NA | 05 Feb 2026 | 261.70 | 285.40 |
Announcements
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
5 days ago
5 days agoBoard Meeting Intimation for Inter-Alia Considering And Approving Audited (Standalone And Consolidated) Financial Results Of The Company For Quarter And FY 2025-26 And To Consider Recommendation Of Dividend If Any On Equity Shares Of Company For FY 2025-7 days ago
7 days agoCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 06, 2026
Apr 06, 2026Closure of Trading WindowMar 20, 2026
Mar 20, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 02, 2026
Mar 02, 2026Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Mar 02, 2026
Mar 02, 2026Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 12, 2026
Feb 12, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 06, 2026
Feb 06, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 06, 2026
Feb 06, 2026Announcement under Regulation 30 (LODR)-Investor PresentationFeb 05, 2026
Feb 05, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 05, 2026
Feb 05, 2026Financial Results Of The Company For The Quarter And Nine Months Ended 31 December 2025 Along With The Limited Review Report.Feb 05, 2026
Feb 05, 2026Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E. Thursday 05 February 2026Feb 05, 2026
Feb 05, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 29, 2026
Jan 29, 2026Board Meeting Intimation for The Board Meeting To Be Held On Thursday 05 February 2026Jan 27, 2026
Jan 27, 2026Intimation Regarding Change In Name Of Statutory Auditor Of The Company Pursuant To Conversion Into LLPJan 16, 2026
Jan 16, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 12, 2026
Jan 12, 2026Closure of Trading WindowDec 22, 2025
Dec 22, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 08, 2025
Dec 08, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 02, 2025
Dec 02, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 14, 2025
Nov 14, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 11, 2025
Nov 11, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 11, 2025
Nov 11, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 10, 2025
Nov 10, 2025Announcement under Regulation 30 (LODR)-Investor PresentationNov 10, 2025
Nov 10, 2025Financial Results Of The Company For The Quarter And Six Months Ended 30 September 2025Nov 10, 2025
Nov 10, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E. Monday 10 November 2025Nov 10, 2025
Nov 10, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 05, 2025
Nov 05, 2025Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Nov 03, 2025
Nov 03, 2025Announcement under Regulation 30 (LODR)-Credit RatingOct 09, 2025
Oct 09, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 09, 2025
Oct 09, 2025Closure of Trading WindowSep 22, 2025
Sep 22, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 18, 2025
Sep 18, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 08, 2025
Sep 08, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 05, 2025
Sep 05, 2025Announcement Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Clarification On AGM ResolutionSep 04, 2025
Sep 04, 2025Weblink Letter To Shareholders As Per Regulation 36(1)(B) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Aug 21, 2025
Aug 21, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 18, 2025
Aug 18, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 18, 2025
Aug 18, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 18, 2025
Aug 18, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 18, 2025
Aug 18, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 14, 2025
Aug 14, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 13, 2025
Aug 13, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 13, 2025
Aug 13, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 13, 2025
Aug 13, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 12, 2025
Aug 12, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 11, 2025
Aug 11, 2025Announcement under Regulation 30 (LODR)-Investor PresentationAug 09, 2025
Aug 09, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 09, 2025
Aug 09, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 09, 2025
Aug 09, 2025Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 Aditya Birla Sun Life ELSS Tax Saver Direct-Growth | 0.32% | 0 | 0.00% | 0.04% | |
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-Growth | 1.06% | 0 | 0.00% | 0.17% | |
 Bandhan Balanced Advantage Fund Direct-Growth | 0.30% | 0 | 0.00% | 0.03% | |
Bandhan BSE Healthcare Index Fund Direct-Growth | 0.04% | 0 | 0.00% | 0.01% | |
Bandhan Innovation Fund Direct-Growth | 0.60% | 0 | 0.00% | 0.04% | |
 Groww ELSS Tax Saver Fund Direct-Growth | 0.00% | 0 | 0.00% | 0.00% | |
Groww Multicap Fund Direct-Growth | 0.00% | 0 | 0.00% | 0.00% | |
Groww Value Fund Direct-Growth | 0.00% | 0 | 0.00% | 0.00% | |
 JM ELSS Tax Saver Fund Direct Plan-Growth | 0.00% | 0 | 0.00% | 0.00% | |
JM Small Cap Fund Direct-Growth | 1.19% | 0 | 0.00% | 0.02% | |
JM Value Fund Direct Plan-Growth | 0.81% | 0 | 0.00% | 0.07% | |
 Kotak Small Cap Fund Direct-Growth | 0.54% | 0 | 0.00% | 0.05% | |
 Nippon India Pharma Fund Direct-Growth | 1.32% | 0 | 0.00% | 0.20% | |
 Quant Consumption Fund Direct-Growth | 0.00% | 0 | 0.00% | 0.00% | |
Quant Healthcare Fund Direct-Growth | 0.00% | 0 | 0.00% | 0.00% |
Technical Indicators
RSI(14)
Neutral 59.42
ATR(14)
Less Volatile 11.18
STOCH(9,6)
Neutral 59.77
STOCH RSI(14)
Neutral 27.21
MACD(12,26)
Bullish 0.60
ADX(14)
Strong Trend 45.19
UO(9)
Bearish 48.90
ROC(12)
Uptrend And Accelerating 5.48
WillR(14)
Neutral -44.16
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
